SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 32.13-0.5%Nov 28 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Edward Paule who wrote (5067)12/9/1997 9:44:00 AM
From: Arthur Radley  Read Replies (1) of 17367
 
Edward,
The very reason that I stopped my subs. to Murphy and these other guys. Here Murphy had Xoma a best place to put money in his newsletter for most of the year and now when he has a chance to really tout the stock he goes with something else.

As for McCamant going with Nexstar as his pick for 1998, I find this a joke. Their Ambisone drug is finding rejections here in the states because of the high price and the fact that competing drugs do the same for less than half the price. For the first time, I think the medical community is price sensitive for drugs. If anything, NXTR would be my candidate for the short of the year. Look at the short interest already in this baby.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext